Application of DSC, IST, and FTIR study in the compatibility testing of nateglinide with different pharmaceutical excipients

被引:84
作者
Pani, Nihar Ranjan [1 ]
Nath, Lila Kanta [1 ]
Acharya, Sujata [2 ]
Bhuniya, Biswanath [3 ]
机构
[1] Dibrugarh Univ, Dept Pharmaceut Sci, Dibrugarh 786004, Assam, India
[2] Utkal Univ, Univ Dept Pharmaceut Sci, Bhubaneswar 751004, Orissa, India
[3] Natl Inst Technol, Dept Biotechnol, Durgapur, W Bengal, India
关键词
Immediate release; Stability; Incompatibility; Drug-excipient interaction; Nateglinide; EXTENDED-RELEASE FORMULATIONS; SCANNING CALORIMETRY; TABLET EXCIPIENTS; SELECTION;
D O I
10.1007/s10973-011-1299-x
中图分类号
O414.1 [热力学];
学科分类号
摘要
Experiments were done to assess the compatibility of nateglinide (NTG) with selected excipients in the development of immediate release tablets of NTG by thermal and isothermal stress testing (IST) techniques. To evaluate the drug excipient compatibility, different techniques such as differential scanning calorimetric (DSC) study, infrared (IR) spectrophotometric study, and IST were adopted. The results of DSC study showed that magnesium stearate exhibited some interaction with NTG. However, the results of IR and IST studies showed that all the excipients used in the formula were compatible with NTG. The optimized formulation developed using the compatible excipients were found to be stable after 3 months of accelerated stability studies (40 +/- 2 degrees C and 75 +/- 5% RH). Overall, compatibility of excipients with NTG was successfully evaluated using the combination of thermal and IST methods and the formulations developed using the compatible excipients was found to be stable.
引用
收藏
页码:219 / 226
页数:8
相关论文
共 19 条
[1]   Application of differential scanning calorimetry to the study of drug-excipient compatibility [J].
Balestrieri, F ;
Magri, AD ;
Magri, AL ;
Marini, D ;
Sacchini, A .
THERMOCHIMICA ACTA, 1996, 285 (02) :337-345
[2]   COMPATIBILITY STUDY BETWEEN NAPROXEN AND TABLET EXCIPIENTS USING DIFFERENTIAL SCANNING CALORIMETRY [J].
BOTHA, SA ;
LOTTER, AP .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1990, 16 (04) :673-683
[3]   Drug-excipient compatibility studies - Search of interaction indicators [J].
Bruni, G ;
Amici, L ;
Berbenni, V ;
Marini, A ;
Orlandi, A .
JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY, 2002, 68 (02) :561-573
[4]   IDENTIFICATION OF STABILIZING AND DESTABILIZING EFFECTS OF EXCIPIENT-DRUG INTERACTIONS IN SOLID DOSAGE FORM DESIGN [J].
DURIG, T ;
FASSIHI, AR .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1993, 97 (1-3) :161-170
[5]  
FDA/CDER, DISS METH LIST ALL D
[6]   DRUG-EXCIPIENT INCOMPATIBILITY STUDIES OF THE DIPEPTIDE ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR, MOEXIPRIL HYDROCHLORIDE - DRY POWDER VS WET GRANULATION [J].
GU, L ;
STRICKLEY, RG ;
CHI, LH ;
CHOWHAN, ZT .
PHARMACEUTICAL RESEARCH, 1990, 7 (04) :379-383
[7]   Spectrophotometric determination of nateglinide in bulk and tablet dosage forms [J].
Jain, Suresh ;
Bhandari, Anil ;
Purohit, Suresh .
ASIAN JOURNAL OF PHARMACEUTICS, 2009, 3 (03) :218-221
[8]  
Kandarapu R, 2001, STP PHARMA SCI, V11, P449
[9]   Application of differential scanning calorimetry and high performance liquid chromatography to determine the effects of mixture composition and preparation during the evaluation of niclosamide-excipient compatibility [J].
Malan, CEP ;
deVilliers, MM ;
Lotter, AP .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1997, 15 (04) :549-557
[10]   Clinical pharmacokinetics of nateglinide - A rapidly-absorbed, short-acting insulinotropic agent [J].
McLeod, JF .
CLINICAL PHARMACOKINETICS, 2004, 43 (02) :97-120